Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus

• Yi-Giien Tsai,
• Yi-Giien Tsai,
• Yi-Giien Tsai,
• Yi-Giien Tsai,
• Pei-Fen Liao,
• Pei-Fen Liao,
• Kai-Hung Hsiao,
• Hung-Ming Wu,
• Ching-Yuang Lin,
• Kuender D. Yang,
• Kuender D. Yang

Affiliations

Yi-Giien Tsai

Department of Pediatrics, Changhua Christian Children’s Hospital, Changhua, Taiwan

Yi-Giien Tsai

School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Yi-Giien Tsai

School of Medicine, Chung Shan Medical University, Taichung, Taiwan

Yi-Giien Tsai

Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan

Pei-Fen Liao

School of Medicine, Chung Shan Medical University, Taichung, Taiwan

Pei-Fen Liao

Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan

Kai-Hung Hsiao

Department of Allergy, Immunology and Rheumatology, Changhua Christian Hospital, Changhua, Taiwan

Hung-Ming Wu

Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan

Ching-Yuang Lin

Division of Pediatric Nephrology, Children’s Hospital, China Medical University Hospital, Taichung, Taiwan

Kuender D. Yang

Department of Pediatrics, Mackay Memorial Hospital, New Taipei City, Taiwan

Kuender D. Yang

0Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan